Navigation Links
NewCardio to Sponsor and Present at 4th Annual Cardiac Safety Assessment Summit
Date:12/22/2009

>CBI Research, Inc. is a subsidiary of Advanstar Communications Inc, and dedicated to developing market-driven, unbiased conferences in the fields of pharmaceuticals and biotech, medical devices, risk and insurance and managed care markets. CBI Research, Inc. creates conferences and summits that serve senior executives and government officials by providing a unique platform for highly focused content and presentation. The Cardiac Safety Assessment Summit will provide sessions to discuss how to measure and manage cardiac safety issues such as Arrhythmia, Ischemic Heart Disease, Cardiomyopothy and drugs that effect heart rate and blood pressure. Cardiac safety considerations in Cardiovascular, Oncology, HIV and Diabetes drugs are also explored. More information is available at http://www.cbinet.com/show_conference.cfm?confCode=PC10102&field=summary online.

About NewCardio, Inc.

NewCardio is a cardiac diagnostic and services company focused on the development of a proprietary platform technology to provide higher accuracy to, and increase the value of, the standard 12-lead electrocardiogram (ECG). NewCardio's development-stage software and hardware products and services are intended to improve the diagnosis and monitoring of cardiovascular disease (CVD), as well as cardiac safety assessment of drugs under development. NewCardio's three-dimensional ECG platform is designed to reduce the time and expense involved in assessing cardiac status while increasing the ability to diagnose clinically significant conditions which were previously difficult to detect. For more information, visit www.newcardio.com.

Forward-Looking Statements

This press r
'/>"/>

SOURCE NewCardio, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NewCardio Announces Master Services Agreement With Dedicated Phase I
2. NewCardio Leadership to Present Two Abstracts at ISCE Conference
3. Vincent W. Renz Joins NewCardio as President
4. NewCardio Announces Positive Results From Third Clinical Validation Study
5. Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation
6. AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float
7. Stipkala LLC to Sponsor SEBIO 2009
8. Boston Scientific Announces Sponsorship of World Diabetes Day Campaign 2009
9. Stipkala LLC to Sponsor Texas Life Science Conference November 12-13, 2009
10. EPIX Pharmaceuticals Announces FDA Approval of a Physician-Sponsored IND for Fourth 6-month Open Label Extension of PRX-03140 for Alzheimers Disease Patient
11. FDA Warning Letters Caused Dramatic Decline in Sponsored Link Exposures, According to comScore
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Sept. 19, 2014  The board of directors of ... quarterly cash dividend of $0.42 per share.  ... to stockholders of record at the close of business ... is a global, research-based biopharmaceutical company formed in 2013 ... use its expertise, dedicated people and unique approach to ...
(Date:9/19/2014)... RESEARCH TRIANGLE PARK, N.C. , Sept. 19, ... company focused on cloud-based drug design and development, ... strategy. The company,s mission is to design new ... Phase 1 and 2 partners to further their ... enhance its portfolio investments. To support this business ...
(Date:9/19/2014)... DUBLIN , Sept. 19, 2014 Research ... "Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) ... For the purposes of this report, the human ... The human microbiome market is expected to be ... grow at a CAGR of 22.3% within the forecast period ...
Breaking Medicine Technology:Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule 2Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 2Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 3
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) will ... community on Thursday, December 8, 2011 from 8:00 a.m. ... New York City.  Members of BioMarin,s management team and ... product portfolio and advancements in the research and development ...
... 17, 2011 Eli Lilly and Company (NYSE: ... more than $4 million in additional funding to the ... to continue its early phase drug discovery efforts focused ... against tuberculosis, including multidrug-resistant strains known as MDR-TB. In ...
Cached Medicine Technology:BioMarin to Host a Research and Development Day on December 8th 2Lilly Provides Additional Funding to Infectious Disease Research Institute to Identify New Tuberculosis Therapies 2Lilly Provides Additional Funding to Infectious Disease Research Institute to Identify New Tuberculosis Therapies 3Lilly Provides Additional Funding to Infectious Disease Research Institute to Identify New Tuberculosis Therapies 4
(Date:9/21/2014)... 21, 2014 The Laboratory Testing Services ... manufacturers perform tests on items ranging from consumer and ... society, pressure on operators to ensure the safety and ... greater number of government safety regulations and consumer lawsuits ... to sale. Although revenue briefly dipped in 2009 as ...
(Date:9/21/2014)... "I wanted to be able to ... sugary, foul-tasting energy drinks," said an inventor from Fresh ... to drink plain, old coffee. That is why I ... developed ENERG CHEWING GUM to provide a healthy energy ... formula contains nutritious vitamins, minerals and antioxidants. It also ...
(Date:9/21/2014)... 21, 2014 The Illinois Joining ... host a statewide symposium ( tinyurl.com/ILBHC14 ) focused ... their Families. Sponsored by the VNA Foundation, Thresholds, ... Grant, and Health & Disability Advocates, the symposium ... Hilton Hotel in Springfield, IL. The symposium ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 The ... implements and supports electronic medical records (EMR) and ... from federal healthcare legislation during the past five ... so during the five years to 2019. The ... Health Act established Medicare and Medicaid incentives to ...
(Date:9/21/2014)... Discount-Dress.com, a company that specializes ... its decision to implement a new shopping cart software ... across the world. Furthermore, the company has unveiled a ... , The new items come in fashionable designs; all ... to 56 percent off. "We are happy to release ...
Breaking Medicine News(10 mins):Health News:Laboratory Testing Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Laboratory Testing Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Enhancing Clinical Competence to Serve Veterans, a Statewide Symposium 2Health News:Enhancing Clinical Competence to Serve Veterans, a Statewide Symposium 3Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 4Health News:Discount-Dress.com Implements A New Shopping Cart Software And Provides New Beach Wedding Dresses 2
... million, Five-year Grant, from New York State Department of,Health, ... Lead,Poisoned, NEW YORK, Feb. 11 The Lead ... Montefiore,(CHAM) has been named one of three State Regional ... healthcare delivery for children and,pregnant women with elevated blood ...
... Part of MedCath,s Growth Plans, CHARLOTTE, N.C., Feb. ... physician partners today announced plans to double,the number of ... a 120-bed acute care and heart hospital., The ... into 60 inpatient beds, which will be used to ...
... from the UC Davis M.I.N.D. Institute shows that an ... be linked with the repetitive behavior also called ... studies are needed to confirm the outcome, this result ... prenatal period could be a causal factor for the ...
... SOUTH SAN FRANCISCO, Calif., Feb. 11 ... SpA have announced an agreement granting,an exclusive ... distribution of,Anesiva,s Zingo(TM) (lidocaine hydrochloride monohydrate) powder,intradermal ... France,Germany, Netherlands, Belgium and Luxembourg. Under the ...
... Unlike other epilepsy meds, Trileptal was no better than ... -- The epilepsy drug oxcarbazepine (Trileptal) does not seem ... finds. , Migraines affect more than 28 million Americans, ... effective in preventing these severe headaches. For this reason, ...
... American Academy of ... Dermatology, ... that validates the benefits of alpha-hydroxy acid (AHA),at- home peels in ... as lasers and microdermabrasion. The,data were highlighted in the Poster Session ...
Cached Medicine News:Health News:Montefiore Lead Poisoning Prevention ProgramNamed One of Three State Regional Resource Centers 2Health News:MedCath Plans 60-bed Expansion at TexSAn Heart Hospital 2Health News:MedCath Plans 60-bed Expansion at TexSAn Heart Hospital 3Health News:Prenatal exposure to maternal antibodies linked to autistic behaviors in offspring 2Health News:Prenatal exposure to maternal antibodies linked to autistic behaviors in offspring 3Health News:Anesiva and Sigma-Tau Announce Exclusive Marketing and Distribution Agreement for Zingo(TM) in Six European Countries 2Health News:Anesiva and Sigma-Tau Announce Exclusive Marketing and Distribution Agreement for Zingo(TM) in Six European Countries 3Health News:Epilepsy Drug Doesn't Prevent Migraines 2Health News:NeoStrata Research Validates Anti-Aging Benefits of At-Home AHA Peels As Complement to In-Office Non-Invasive Cosmetic Procedures 2
... Super High Density, multi-frequency, linear ... "twist on the UST-5536, this ... it sweeps horizontally as well ... axis so that target lesions ...
Super High Density, multi-frequency, end-fire phased array transducer. Point-and-shoot scanning is the benefit of this transducer....
This is a 3D transducer for endovaginal imaging in OB/GYN....
This is a 3D transducer for endovaginal imaging in OB/GYN....
Medicine Products: